The Drug Company That Prospered Without Creating Any Drugs
A look at Horizon Therapeutics' tactics
Stay updated with breaking news from Its Vimovo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A look at Horizon Therapeutics' tactics
Horizon Therapeutics, which Amgen is acquiring for about $28 billion, grew large by snapping up cheap drugs from other companies, marketing them to perfection, and jacking up prices.
The new drug looked so promising — except for that one warning sign.
Horizon Therapeutics, which Amgen is acquiring for about $28 billion, grew large by snapping up cheap drugs from other companies, marketing them to perfection, and jacking up prices.
Horizon grew large by snapping up cheap drugs from other companies, marketing them to perfection, and jacking up prices.